Cellectis (CLLS) Misses Q4 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.22 million versus the consensus estimate of $21.71 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance